Integrated Chinese and Western Therapy for Cancer-Related Fatigue
Clinical Effectiveness Assessment of Integrated Chinese and Western Therapy for Cancer-Related Fatigue
1 other identifier
interventional
86
1 country
1
Brief Summary
Cancer-related fatigue (CRF) is a common and debilitating symptom in patients with cancer. Evidence-based non-pharmacological approaches include sleep hygiene, physical activity, nutritional management, and traditional Chinese medicine (TCM). This study evaluates the clinical effectiveness of an interdisciplinary holistic program integrating Chinese and Western therapies for CRF among hospitalized cancer patients receiving integrated care. Approximately 100 participants will be enrolled and followed for up to 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2020
CompletedFirst Submitted
Initial submission to the registry
February 21, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedMarch 3, 2026
February 1, 2026
6 months
February 21, 2026
February 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cancer-Related Fatigue (CRF) Score (0-10)
CRF is assessed using the Taiwan Society of Cancer Palliative Medicine fatigue scale (0-10) during hospitalization. Peak CRF score is defined as the maximum recorded CRF score from admission to discharge. Discharge CRF score is defined as the last in-hospital CRF assessment prior to discharge. The primary outcome is the within-participant change in CRF score from peak to discharge.
From admission (baseline) through discharge (last in-hospital assessment; up to 30 days)
Secondary Outcomes (2)
Proportion of Participants With Moderate-to-Profound CRF at Discharge (CRF Score ≥4)
At discharge (last in-hospital assessment; up to 30 days after admission)
Distribution of CRF Severity Categories at Discharge (0, 1-3, 4-6, 7-8, 9-10)
At discharge (last in-hospital assessment; up to 30 days after admission)
Study Arms (1)
Integrated Chinese and Western Holistic Care
EXPERIMENTALAll participants receive an integrated Chinese and Western holistic care program during hospitalization for cancer-related fatigue management. The program includes routine fatigue assessment and individualized supportive care measures (education, sleep hygiene, exercise encouragement, aromatherapy and/or massage, nutrition consultation, and shared decision-making). Traditional Chinese Medicine consultation (e.g., acupuncture and/or Chinese herbal medicine) may be provided when clinically indicated.
Interventions
An interdisciplinary integrative care program combining Western supportive care and Traditional Chinese Medicine to manage cancer-related fatigue in hospitalized oncology patients. Core components include fatigue assessment, patient education and symptom management guidance, sleep hygiene, exercise encouragement, aromatherapy and/or massage, nutrition assessment and counseling, and shared decision-making. Traditional Chinese Medicine consultation may provide acupuncture and/or Chinese herbal medicine according to patient needs and clinical judgment.
Eligibility Criteria
You may qualify if:
- Signed informed consent form.
- Age 20 to 95 years.
- Receiving integrated Chinese and Western holistic care.
- Agree to provide clinically relevant data for this study.
You may not qualify if:
- Refuse to continue participation during the study period, or the family requests discontinuation (withdrawal).
- Psychiatric disorder that makes the participant unable to cooperate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taichung Tzu Chi Hospital
Taichung, 42743, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
February 21, 2026
First Posted
March 3, 2026
Study Start
November 8, 2019
Primary Completion
April 22, 2020
Study Completion
April 22, 2020
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share